enVVeno Medical Corp. (NVNO)
6.65
-0.26
(-3.76%)
USD |
NASDAQ |
Oct 23, 16:00
6.60
-0.05
(-0.75%)
After-Hours: 20:00
enVVeno Medical Enterprise Value : -16.51M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -16.51M |
| October 22, 2026 | -16.33M |
| October 21, 2026 | -16.05M |
| October 20, 2026 | -15.80M |
| October 19, 2026 | -15.81M |
| October 16, 2026 | -15.95M |
| October 15, 2026 | -15.65M |
| October 14, 2026 | -16.00M |
| October 13, 2026 | -15.62M |
| October 12, 2026 | -15.50M |
| October 09, 2026 | -15.09M |
| October 08, 2026 | -15.48M |
| October 07, 2026 | -15.33M |
| October 06, 2026 | -15.46M |
| October 05, 2026 | -15.59M |
| October 02, 2026 | -15.53M |
| October 01, 2026 | -15.57M |
| September 30, 2026 | -15.73M |
| September 29, 2026 | -15.18M |
| September 28, 2026 | -15.05M |
| September 25, 2026 | -15.15M |
| September 24, 2026 | -14.86M |
| September 23, 2026 | -14.95M |
| September 22, 2026 | -14.86M |
| September 21, 2026 | -14.89M |
| Date | Value |
|---|---|
| September 18, 2026 | -14.94M |
| September 17, 2026 | -15.06M |
| September 16, 2026 | -14.89M |
| September 15, 2026 | -14.71M |
| September 14, 2026 | -14.67M |
| September 11, 2026 | -13.92M |
| September 10, 2026 | -13.50M |
| September 09, 2026 | -13.51M |
| September 08, 2026 | -13.25M |
| September 04, 2026 | -13.28M |
| September 03, 2026 | -13.51M |
| September 02, 2026 | -13.38M |
| September 01, 2026 | -13.59M |
| August 31, 2026 | -13.26M |
| August 28, 2026 | -13.75M |
| August 27, 2026 | -13.42M |
| August 26, 2026 | -13.26M |
| August 25, 2026 | -13.71M |
| August 24, 2026 | -14.02M |
| August 21, 2026 | -14.06M |
| August 20, 2026 | -13.99M |
| August 19, 2026 | -13.93M |
| August 18, 2026 | -13.55M |
| August 17, 2026 | -13.04M |
| August 14, 2026 | -13.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 207.10B |
| AngioDynamics, Inc. | 501.34M |
| Alphatec Holdings, Inc. | 2.205B |
| AtriCure, Inc. | 2.906B |
| Baxter International, Inc. | 19.76B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.60M |
| Total Expenses (Quarterly) | 3.60M |
| EPS Diluted (Quarterly) | -5.365 |
| Earnings Yield | -376.6% |
| Normalized Earnings Yield | -373.50 |